GLYCINE B ANTAGONISTS

The invention relates to 2(1H)-quinolinone derivatives of formula (I) as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the contro...

Full description

Saved in:
Bibliographic Details
Main Authors PISKUNOVA, IRENA, WOLTER, FALKO ERNST, KRUEGER, BJOERN, SEMENIHINA, VALENTINA, ROZHKOVS, JEVGENIJS, KAUSS, VALERJANS, HANSEN, ANGELA, PELSS, JURIS, ABEL, ULRICH
Format Patent
LanguageEnglish
French
Published 06.12.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to 2(1H)-quinolinone derivatives of formula (I) as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders. L'invention concerne des dérivés de la 2(1H)-quinolinone représentés par la formule (I), ainsi que les sels pharmaceutiquement acceptables de ceux-ci. L'invention concerne de plus un procédé de préparation de tels composés. Les composés de l'invention constituent des antagonistes de la glycine B, et sont par conséquent utiles pour réguler et prévenir divers troubles, y compris des troubles neurologiques.
Bibliography:Application Number: WO2012EP60433